0001209191-23-052621.txt : 20231011 0001209191-23-052621.hdr.sgml : 20231011 20231011161007 ACCESSION NUMBER: 0001209191-23-052621 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231010 FILED AS OF DATE: 20231011 DATE AS OF CHANGE: 20231011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yu Yong CENTRAL INDEX KEY: 0001937482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41599 FILM NUMBER: 231320815 MAIL ADDRESS: STREET 1: C/O GENELUX CORPORATION STREET 2: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER NAME: FORMER CONFORMED NAME: Yu Tony DATE OF NAME CHANGE: 20220711 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENELUX Corp CENTRAL INDEX KEY: 0001231457 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 805-267-9889 MAIL ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENELUX CORP DATE OF NAME CHANGE: 20030508 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-10 0 0001231457 GENELUX Corp GNLX 0001937482 Yu Yong C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 0 1 0 0 VP, Clinical Trial Operations 0 Common Stock 2023-10-10 4 M 0 5200 6.00 A 111335 D Common Stock 2023-10-10 4 S 0 4800 21.9374 D 106535 D Common Stock 2023-10-10 4 S 0 400 22.906 D 106135 D Stock Option (right to buy) 6.00 2023-10-10 4 M 0 5200 0.00 D 2029-09-20 Common Stock 5200 212853 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023. The weighted average sale price for the transaction reported was $21.9374, and the range of prices were between $21.54 and $22.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $22.906, and the range of prices were between $22.82 and $22.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Immediately exercisable. /s/ Sean Ryder, Attorney-in-Fact 2023-10-11